Showing 21 - 40 results of 117 for search '(((( euploid cell decrease ) OR ( euploid fold decrease ))) OR ( myeloid small decrease ))', query time: 0.98s Refine Results
  1. 21
  2. 22

    Table_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.xlsx by Kanwal M. Hameed (18386853)

    Published 2024
    “…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”
  3. 23

    DataSheet_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.pdf by Kanwal M. Hameed (18386853)

    Published 2024
    “…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”
  4. 24

    Table1_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.xlsx by Akifumi Ijuin (16817115)

    Published 2023
    “…</p><p>Discussion: Our results indicate that aneuploid cells decrease in human embryos post-implantation, and mtDNA mutations might induce low mitochondrial function and influence the development of post-implantation embryos with not only aneuploidy but also euploidy. …”
  5. 25

    Table5_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.DOCX by Akifumi Ijuin (16817115)

    Published 2023
    “…</p><p>Discussion: Our results indicate that aneuploid cells decrease in human embryos post-implantation, and mtDNA mutations might induce low mitochondrial function and influence the development of post-implantation embryos with not only aneuploidy but also euploidy. …”
  6. 26
  7. 27
  8. 28

    Image3_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

    Published 2022
    “…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
  9. 29

    Image1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

    Published 2022
    “…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
  10. 30

    Image2_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

    Published 2022
    “…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
  11. 31

    DataSheet1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.xlsx by Xingrong Lai (12526789)

    Published 2022
    “…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
  12. 32

    DataSheet_1_Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia.pdf by Carlos C. Smith-Díaz (11312490)

    Published 2021
    “…We found that the addition of ascorbate had a minimal effect on Prima-1<sup>Met</sup>–induced cytotoxicity, with small increases or decreases in cytotoxicity being observed depending on the timing of treatment. …”
  13. 33

    LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells by Zhongtao Yuan (8747427)

    Published 2020
    “…<p><b>Objectives:</b> Long non-coding RNA (lncRNA) small nucleolar RNA host gene 4 (SNHG4) is a characterized oncogenic lncRNA in osteosarcoma. …”
  14. 34

    Image_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
  15. 35

    Table_7_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
  16. 36

    Table_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
  17. 37

    Table_8_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
  18. 38

    Image_1_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
  19. 39

    Image_4_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
  20. 40

    Image_5_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif by Joseph R. Podojil (12050717)

    Published 2022
    “…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”